# Anteris Technologies extends manufacturing agreement with LeMaitre for CardioCel and VascuCel

Anteris Technologies signed a nine-month extension to its manufacturing contract with LeMaitre Vascular Inc. on August 30, 2021, to continue producing CardioCel and VascuCel at its Malaga facility in Western Australia until July 2023.

- Type: Contract
- Announced: 2021-08-30
- Where: Malaga, Western Australia, Australia
- Status: announced
- Products: CardioCel, VascuCel
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Anteris Technologies](https://endata.com/companies/57360.md)
- [LeMaitre Vascular](https://endata.com/companies/42722.md) (customer)

## Sources

- [listcorp.com](https://www.listcorp.com/asx/avr/anteris-technologies-ltd/news/extended-manufacturing-agreement-2584841.html), 2021-08-29: "This extension helps maximise the capacity utilization of our facility in Australia as we continue to manufacture."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.